The present invention relates to chemical compounds having inhibitory activity on an intermediate conductance Ca 2+ activated potassium channel (IK Ca), and the use of such compounds for the treatment or alleviation of diseases or conditions relating to immune dysfunction. Moreover, the invention relates to a method of screening a chemical compound for inhibitory activity on an intermediate conductance Ca 2+ activated potassium channel (IK Ca).
本发明涉及具有对中间电导性Ca2+激活
钾通道(IK Ca)具有抑制活性的化合物,以及利用这种化合物治疗或缓解与免疫功能紊乱相关的疾病或症状。此外,本发明涉及一种筛选化合物对中间电导性Ca2+激活
钾通道(IK Ca)具有抑制活性的方法。